|
The Pharmaceutical
Journal Vol 267 No 7171 p613-615 |
A review of pharmacy continuing professional development |
|
By Fawz Farhan |
|
|
The debate over whether practising pharmacists should have to undertake continuing professional development throughout their careers is over. The only outstanding discussions concern the practicalities. This feature reviews the current position and sets out some of the available courses that lead to formal qualifications |
|
The Royal Pharmaceutical Society has decided that mandatory continuing professional development is the way forward for the profession. Earlier this month it moved a step further towards this goal with the announcement that it plans the gradual introduction of a voluntary continuing professional development (CPD) scheme, starting in 2002, with the aim of a seamless transition to a mandatory system when the appropriate legislation comes through. The news is a wake-up call to pharmacists everywhere. "Undertake CPD or you're out," is the message. Pharmacists will have to demonstrate to the Society that they are undertaking CPD but whether in reality this could be linked to revalidation and remaining on the register is still unclear. Costs, practicalities of assessment and legislation are all issues that will need to be addressed first. Focus on mandatory CPD The news that mandatory CPD is on its way should come as no surprise. It has been driven by both internal and external forces. Internally, the profession has realised for a number of years that it must move with the times if it wants to take on extended roles (and be paid for them), develop patient care and be taken seriously by the multidisciplinary team and by government. That means undertaking continuing education and continuing professional development and demonstrating clinical governance. Externally, government has recognised that pharmacists can meet some of its NHS plans more cost-effectively than other health professionals. However, pharmacists need to prove to the Government and to society that they are capable of, and competent to take on, these new roles. In May this year, the Society submitted its proposals for mandatory CPD to the Department of Health with the hope of legislation, through a Parliamentary Order, being granted by the end of the year. This now seems unlikely, says Robert Dewdney, head of education at the Society, as the Department seems to be heavily engaged in other policies from the NHS plan. "It is a priority among other priorities," he explains. While dealing with these other priorities, the Department has also realised that there are common issues running in the other health care professions that could be better and more efficiently addressed by an overarching body. As a result, the Department of Health set up a regulatory health framework in August to oversee the regulation of health professions. The Department may therefore wait to hear what this body has to say before progressing with the Order for mandatory CPD. The phrase "standing still is no longer an option" applies aptly to the CPD situation in pharmacy. Following the developments at the Department of Health, the CPD advisory group, which was overseeing the Society's CPD pilot, advised the Council that it was time to progress to a voluntary CPD system until the legislation was passed. This means that the CPD framework can progress and be put in place on a voluntary basis, ready to be switched to a mandatory scheme when the time comes. Setting the CPD framework At its October meeting, the Council reaffirmed investment in, and implementation of, a voluntary scheme by the end of 2002. Its first job was to set up a CPD implementation committee to oversee the framework for the voluntary CPD scheme. This committee is expected to be formed around February next year once the Council has approved the committee members. The voluntary scheme will be based on the Society's CPD pilot and will involve pharmacists maintaining a CPD portfolio. They will need to complete the CPD cycle needs assessment, planning, implementation and evaluation according to the activities and responsibilities of their particular jobs. These records of CPD can then be requested by the Society for evaluation. The scheme is "voluntary" in the sense that it will not yet be linked to "revalidation" and remaining on the register. Dr Dewdney hopes to get as many as 5,000 people, with material in hand to get started, by the end of 2002. By the end of 2004, this will have extended at least to everybody engaged in patient care. The CPD implementation committee will decide on who the first 5,000 are. It could be random or it could consist of defined groups such as preregistration tutors, older pharmacists or pharmacists switching fields of practice. Groups may also be identified in terms of risk reduction and public interest. Dr Dewdney believes the voluntary scheme will be driven by a change of emphasis from "should do" to "must do" and by pressure from primary care groups and trusts and employers who will expect a high take-up. Anyone refusing to participate will be challenged by their employer. However, Dr Dewdney admits that, until legislation comes through, the Society can do little to force people to participate in the scheme. Once it does, the switch from voluntary to mandatory could happen very quickly.
Evaluation and revalidation The evaluation process is a fundamental part of this CPD framework as it provides pharmacists with constructive feedback on their personal development. An evaluation system will also be necessary for mandatory CPD as proof of completion of CPD. In its draft proposals, the Council has already stipulated that, for pharmacists to be revalidated or relicensed under the mandatory scheme, they will have to submit satisfactory evidence of CPD. Although there was talk originally about pharmacy postgraduate colleges getting involved in the evaluation process, this is not part of the plans. Dr Dewdney says that evaluators will not necessarily be pharmacists, as they will be assessing learning behaviours rather than clinical knowledge. Evaluators could include other health care professionals, other well-educated people and even patients and representatives of patient groups. However, for professional ownership there will need to be a reasonable quota of pharmacists. The Centre for Pharmacy Postgraduate Education (CPPE) agrees that it does not see itself as being part of the monitoring or evaluation process that the Society is putting into place. CPPE assistant director Angela Triki´c says: "We see ourselves as key education providers. It is a role we are performing and we're pretty good at doing that. A monitoring role would involve a change in function and we have no plans to undertake that." As far as enforcing mandatory CPD and linking it to revalidation is concerned, the CPPE imagines that employers will have a role to play here and will demand it of their employees as part of the contractual arrangement. The Scottish Centre for Post-Qualification Pharmaceutical Education (SCPPE) believes that linking CPD to revalidation may mean in the longer term having a register for practising pharmacists linked to specialist areas and core competencies for that specialist practice. However, pharmacists will need to be supported before these changes materialise. SCPPE director Rose Marie Parr believes it is important to allow ring-fenced time for learning in working hours, and to promote personal development plans and encourage a more "learning organisation" mindset in the NHS and the profession. Guy Thompson, deputy director of the Welsh Centre for Postgraduate Pharmaceutical Education (WCPPE), is not convinced that mandatory CPD and formal assessment is the way forward. His view is that it is not practical and that other health care professions have already tried and failed. "All we want is evidence that a person is undertaking CPD. I don't believe you can assess the finer details of a CPD portfolio." He also adds that the WCPPE would find it very difficult to adopt an assessment role because it would undermine the nature of the relationship it has with Welsh pharmacists. Instead, he believes that CPD should come from within the profession and should be driven by pharmacists wanting self-improvement. Mr Thompson believes the insistence on mandatory CPD is simply a smoke-screen put up by the profession and is in response to society's current dissatisfaction with the medical profession. "If you can demonstrate that the profession is doing what it should do, you divert away the gaze of the Government." Rather than using the CPD portfolio for revalidation, Mr Thompson believes that it can better be used as evidence of competence to practise in defence of pharmacists hauled up before the Statutory Committee. Implications of mandatory CPD The implications of such a fundamental strategy will reach every corner of pharmacy. Pharmacists, pharmacy postgraduate bodies, education providers, employers and health care companies will all be involved. The most obvious and immediate issue is that of funding. Setting up the framework and evaluating pharmacists' CPD will require money. This may be partly funded by pharmacists themselves through their Society retention fees. In August, the Council sought a 31 per cent increase from £142 to £186 "to resource constitutional change and new areas of professional and regulatory activity that meet the Government's quality agenda and modern public expectation of health professionals". This includes CPD and lifelong learning. Another issue, which pharmacists will probably see as even more contentious, is the possible linking of mandatory CPD to revalidation. Pharmacists will need to start thinking seriously about CPD and what it means for them in practice. How will it fit into the normal functions of their job? When will they do it? How much time will they spend on it? Who can they turn to for guidance?
Mass exodus? There has been speculation that it will result in a mass exodus of pharmacists and add to the shortage of pharmacists. Some pharmacists nearing retirement may decide to hang up their boots early rather than have to go through what they see as a patronising rigmarole of providing evidence of CPD. The system may filter out, or even bring into line, pharmacists who are not committed to the ethics and morals of excellence and clinical governance. Pharmacists will be expecting support for CPD from the Society, postgraduate education bodies, health care companies and, particularly, from their employers. If this is not forthcoming, they are likely to feel abandoned. Boots and Lloyds have already produced CPD portfolios for their employees. Guidance is essential in easing pharmacists into the mindset of CPD and it may mean instilling the concept as early as possible, among preregistration trainees or even among undergraduate pharmacy students. Another issue is what should pharmacists do if they want to switch from one area of practice to another. The CPD advisory group is investigating this and it is likely that the register will not be divided according to the sector in which pharmacists work, but will instead indicate the roles that people fit into and the jobs that are within their competence. This is because there are a lot of roles that overlap. In a practical setting, pharmacists who decide to move from community to hospital will need to prove they are competent to practise within the new environment. They would use the CPD cycle and take on the training needed to fulfil the new roles. Pharmacists who switch fields of practice may become a priority group for CPD review by the Society. Whether this is done retrospectively or prospectively is one of the issues that have yet to be decided. Opportunities Employees will be looking with greater scrutiny at the commitment that employers show to training and personal development. With the current shortage of pharmacists, employers have recognised this and have started to look at training and CPD support as a perk to pull in new employees. Pharmacists can also make the most of the training and education that health care companies are getting involved in. However, they will need to be more discerning in which ones they take up. Material that is pitched at the right level and fulfils a genuine learning need will be invaluable. Training and education that supports medicine management initiatives will also be valued. Independent pharmacists often lack the support and network that multiples have and that includes support from a training department. The National Pharmaceutical Association, wholesalers and buying groups have recognised that they have a role to play here and are increasingly getting involved in education and training as part of their service to independents. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal